| Literature DB >> 27172188 |
Simon Ipcho1, Thomas Sundelin1, Gitte Erbs1, H Corby Kistler2, Mari-Anne Newman1, Stefan Olsson3.
Abstract
Plants and animals detect bacterial presence through Microbe-Associated Molecular Patterns (MAMPs) which induce an innate immune response. The field of fungal-bacterial interaction at the molecular level is still in its infancy and little is known about MAMPs and their detection by fungi. Exposing Fusarium graminearum to bacterial MAMPs led to increased fungal membrane hyperpolarization, a putative defense response, and a range of transcriptional responses. The fungus reacted with a different transcript profile to each of the three tested MAMPs, although a core set of genes related to energy generation, transport, amino acid production, secondary metabolism, and especially iron uptake were detected for all three. Half of the genes related to iron uptake were predicted MirA type transporters that potentially take up bacterial siderophores. These quick responses can be viewed as a preparation for further interactions with beneficial or pathogenic bacteria, and constitute a fungal innate immune response with similarities to those of plants and animals.Entities:
Keywords: MAMPs; fungal–bacterial interaction; innate immunity; transcriptomics
Mesh:
Substances:
Year: 2016 PMID: 27172188 PMCID: PMC4889655 DOI: 10.1534/g3.116.027987
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Figure 1Effect of MAMPs on fungal membrane potential. A dye that incorporates into live membranes and fluoresces in response to membrane polarization was used to investigate if fungi recognize MAMPs. Upon exposure to the elicitors, the membrane polarization increased sharply during the first 2 hr. The net effect is shown as Relative Fluorescence Units (RLU) for treatment minus RLU-control (RLU T-C). N= 6; Error bars = SE. FLG, flagellin; LOS, lipo-oligosaccharides; MAMPs, microbe-associated molecular patterns.
Figure 2The number of genes differentially induced by MAMPs. The Venn diagram shows the number of significantly up-regulated genes identified when the fungus was treated with either LOS, PGN, or FLG, and compared against a water control. (A) Genes regulated after 1 hr. (B) Genes regulated after 2 hr. (C) Genes regulated after 4 hr. (D) The Venn diagram shows the number of nonredundant genes that was induced by each MAMP at any one of the tested times. FLG, flagellin; LOS, lipo-oligosaccharides; MAMPs, microbe-associated molecular patterns; PGN, peptidoglycans.
Figure 3The number of genes differentially repressed by MAMPs. The Venn diagram shows the number of significantly down-regulated genes identified when the fungus was treated with either, LOS, PGN, or FLG, and compared against a water-treated culture. (A) Genes regulated after 1 hr. (B) Genes regulated after 2 hr. (C) Genes regulated after 4 hr. (D) The number of unique genes that was repressed at any of the tested times by each MAMP. FLG, flagellin; LOS, lipo-oligosaccharides; MAMPs, microbe-associated molecular patterns; PGN, peptidoglycans.
Functional categories that were significantly enriched (P < 0.01) when MAMPs-regulated genes were analyzed
| Functional Category | Differentially Expressed Genes Identified | FUNCAT Related Genes in Genome | |
|---|---|---|---|
| Genes up-regulated | |||
| 01 Metabolism | 29 | 3402 | 6.08E-04 |
| 01.01.11.02 Metabolism of isoleucine | 2 | 25 | 6.46E-03 |
| 01.01.11.03 Metabolism of valine | 2 | 21 | 4.58E-03 |
| 01.01.11.04 Metabolism of leucine | 2 | 31 | 9.83E-03 |
| 01.07 Metabolism of vitamins, cofactors, and prosthetic groups | 6 | 346 | 6.51E-03 |
| 02.10 Tricarboxylic-acid pathway (citrate cycle, Krebs cycle, TCA cycle) | 3 | 54 | 2.26E-03 |
| 20.01 Transported compounds (substrates) | 16 | 1597 | 3.38E-03 |
| 20.01.01 Ion transport | 8 | 321 | 1.53E-04 |
| 20.01.01.01 Cation transport (H+, Na+, K+, Ca2+, NH4+, | 8 | 269 | 4.47E-05 |
| 20.01.01.01.01 Heavy metal ion transport (Cu+, Fe3+, | 8 | 99 | 2.39E-08 |
| 20.01.01.01.01.01 Siderophore-iron transport | 7 | 41 | 8.98E-10 |
| 20.01.27 Drug/toxin transport | 8 | 171 | 1.63E-06 |
| 20.03.22 Transport ATPases | 4 | 123 | 2.97E-03 |
| 20.03.25 ABC transporters | 4 | 106 | 1.73E-03 |
| 20.09 Transport routes | 13 | 1237 | 5.82E-03 |
| 20.09.18 Cellular import | 11 | 519 | 3.58E-05 |
| 20.09.18.07 Nonvesicular cellular import | 8 | 278 | 5.64E-05 |
| 32.07 Detoxification | 9 | 520 | 8.61E-04 |
| 34 Interaction with the environment | 13 | 832 | 1.51E-04 |
| 34.01 Homeostasis | 8 | 336 | 2.09E-04 |
| 34.01.01 Homeostasis of cations | 8 | 290 | 7.59E-05 |
| 34.01.01.01 Homeostasis of metal ions (Na, K, Ca, | 8 | 208 | 6.99E-06 |
| 40.10.02.02 Apoptotic program | 2 | 27 | 7.51E-03 |
| 40.10.02.02.01 Apoptotic mitochondrial changes | 2 | 10 | 1.02E-03 |
| Genes down-regulated | |||
| 01.06.06.13 Tetraterpenes (carotinoids) metabolism | 1 | 3 | 3.68E-03 |
| 01.07 Metabolism of vitamins, cofactors, and prosthetic groups | 4 | 346 | 7.09E-04 |
| 01.07.01 Biosynthesis of vitamins, cofactors, and prosthetic groups | 4 | 179 | 5.67E-05 |
| 01.20.21 Metabolism of sulfuric acid and L-cysteine derivatives | 1 | 8 | 9.80E-03 |
The figures are representative of the 68 genes that were significant induced, and 17 genes that were significantly repressed, by all three MAMPs at any of the three studied times. MAMPs, microbe-associated molecular patterns; FUNCAT, functional category; TCA, tricarboxylic-acid.
Common genes that were significantly induced (57) or repressed (19) by both LOS and PGN at any of the tested times were subject to functional category enrichment analysis
| Functional Category | Differentially Expressed Genes Identified | FUNCAT Related Genes in Genome | |
|---|---|---|---|
| Genes up-regulated | |||
| 01 Metabolism | 25 | 3402 | 1.12E-03 |
| 01.01 Amino acid metabolism | 12 | 649 | 1.05E-05 |
| 01.01.03.02 Metabolism of glutamate | 3 | 63 | 2.21E-03 |
| 01.01.03.02.01 Biosynthesis of glutamate | 3 | 41 | 6.34E-04 |
| 01.01.06.04 Metabolism of threonine | 2 | 18 | 2.45E-03 |
| 01.01.06.04.02 Degradation of threonine | 2 | 12 | 1.07E-03 |
| 01.01.11 Metabolism of the pyruvate family (alanine, isoleucine, leucine, and valine) and D-alanine | 5 | 65 | 6.81E-06 |
| 01.01.11.02 Metabolism of isoleucine | 2 | 25 | 4.71E-03 |
| 01.01.11.02.02 Degradation of isoleucine | 2 | 10 | 7.36E-04 |
| 01.01.11.03 Metabolism of valine | 2 | 21 | 3.33E-03 |
| 01.01.11.03.02 Degradation of valine | 2 | 11 | 8.97E-04 |
| 01.01.11.04 Metabolism of leucine | 5 | 31 | 1.56E-07 |
| 01.01.11.04.01 Biosynthesis of leucine | 2 | 21 | 3.33E-03 |
| 01.01.11.04.02 Degradation of leucine | 5 | 19 | 1.11E-08 |
| 01.02.02 Nitrogen metabolism | 3 | 63 | 2.21E-03 |
| 01.02.02.09 Catabolism of nitrogenous compounds | 2 | 28 | 5.89E-03 |
| 01.05 C-compound and carbohydrate metabolism | 15 | 1547 | 1.17E-03 |
| 01.05.02.04 Sugar, glucoside, polyol, and carboxylate anabolism | 3 | 85 | 5.17E-03 |
| 01.05.06 C-2 compound and organic acid metabolism | 5 | 45 | 1.07E-06 |
| 01.05.06.07 C-2 compound and organic acid catabolism | 5 | 39 | 5.15E-07 |
| 01.20.07 Metabolism of propionic acid derivatives | 1 | 1 | 4.12E-03 |
| 02 Energy | 11 | 609 | 3.22E-05 |
| 02.10 Tricarboxylic-acid pathway (citrate cycle, Krebs cycle, and TCA cycle) | 4 | 54 | 7.04E-05 |
| 02.16 Fermentation | 5 | 109 | 8.39E-05 |
| 02.16.11 Propionate fermentation | 3 | 5 | 6.61E-07 |
| 11.04 RNA processing | 7 | 442 | 2.16E-03 |
| 11.04.01 rRNA processing | 6 | 187 | 1.16E-04 |
| 12 Protein synthesis | 7 | 439 | 2.08E-03 |
| 12.01 Ribosome biogenesis | 7 | 255 | 8.05E-05 |
| 32.05.03 Defense-related proteins | 3 | 92 | 6.44E-03 |
| 40.10.02.01 Antiapoptosis | 2 | 31 | 7.19E-03 |
| Genes down-regulated | |||
| 02 Energy | 5 | 609 | 1.13E-03 |
| 02.16 Fermentation | 2 | 109 | 9.65E-03 |
| 20.01.03 C-compound and carbohydrate transport | 3 | 332 | 9.99E-03 |
| 20.01.11 Amine/polyamine transport | 2 | 58 | 2.82E-03 |
| 20.03 Transport facilities | 5 | 808 | 3.94E-03 |
| 20.03.02 Carrier (electrochemical potential-driven transport) | 3 | 142 | 9.11E-04 |
| 20.03.02.03 Antiporter | 2 | 75 | 4.68E-03 |
| 20.03.02.03.01 Proton driven antiporter | 2 | 45 | 1.71E-03 |
The results show those categories that were significantly enriched (P < 0.01). LOS, lipo-oligosaccharides; PGN, peptidoglycans; FUNCAT, functional category; TCA, tricarboxylic-acid; rRNA, ribosomal RNA.
Figure 4Potential transcriptional factor binding sites on the promoter region of MAMP-induced genes. The promoter region of the 68 common MAMP-induced genes and the 57 genes induced by both PGN and LOS were searched for transcription factor binding motifs to potentially identify the transcription factors regulating them. Two major element binding motifs have been identified. (A) All of the common MAMP genes and 16 of the genes induced by both PGN and LOS had a binding motif that potentially binds to the transcription factor AZF1 in yeast, with FGSG_16816 (formerly FGSG_13123) as an ortholog in F. graminearum. (B) 26 genes of the common MAMP genes had promoter sequence similarities to a GATA binding motif that matched the promoter sequence for GLN3 in yeast. The F. graminearum transcription factors FGSG_09565 , FGSG_08634 , and FGSG_16452 (formerly FGSG_05073) have similarities to GLN3. LOS, lipo-oligosaccharides; MAMPs, microbe-associated molecular patterns; PGN, peptidoglycans.
Figure 5Principal component analysis comparison of published F. graminearum transcriptome studies with MAMP transcriptome profiles. The gene expression fold change of treated F. graminarum compared to control from the published F. graminearum transcriptomics studies of Carbon/Nitrogen starvation (F2-C/N), nongerminated conidia (Conidia), 24 hr post plant infection (F1-24), and germinated conidia at 2 or 8 hr (F7-2/8) was used to compare the gene expression fold change compared to control profiles of the MAMPs study. The broken lines connect to an enlarged picture of the area where the MAMPs-treated fungal data and fungal–plant infection data have clustered closely. MAMP datasets are named according to the treatment and exposure time (e.g., FLG1H is data of the changed transcriptome of a fungus exposed to FLG for 1 hr as compared to control). FLG, flagellin; LOS, lipo-oligosaccharides; MAMPs, microbe-associated molecular patterns; PC, principal component; PGN, peptidoglycans.